Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Culture

25 Aug 2023

Harm Reduction at Psychedelic Gatherings: Best Practices and Strategies

Harm reduction measures and other safety strategies are crucial for positive and responsible experiences. We take a closer look....

By Microdose

Culture

24 Aug 2023

Breaking Down Barriers: Creating Inclusive Psychedelic Communities

Exploring challenges and strategies to increase accessibility and diversity in the psychedelic therapy space....

By Microdose

Health & Wellness

23 Aug 2023

Psychedelics and Addiction: How Substances Like Ibogaine Are Revolutionizing Treatment Options

Addiction is a challenging condition that affects millions of individuals worldwide. Substances like Ibogaine can facilitate profound healing and recovery....

By Microdose
psychedelic mushrooms

Culture

22 Aug 2023

The Intersection of Psychedelic Culture, the Environment, and Sustainability

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Health & Wellness

18 Aug 2023

Microdosing for Longevity: A Tool for Healthy Aging?

A look at the research on microdosing psychedelics and how it may help mental health and longevity....

By Microdose

Culture

17 Aug 2023

Breaking the Stigma: How Psychedelic Advocacy is Changing Public Perception

Advocates are working to educate the public on the benefits of psychedelics, helping to dispel myths and increase access....

By Microdose

Culture

16 Aug 2023

Beyond the Trip: Nurturing a Healthy Psychedelic Lifestyle

We explore the aspects of a holistic psychedelic lifestyle, including integration work, ongoing education, self-care, and community involvement....

By Microdose

Culture

15 Aug 2023

Psychedelic Tourism: A Look at Ethics, Sustainability, and Safety

Exploring psychedelic tourism, with a focus on ethical considerations, sustainability, and strategies to ensure safety and respect for indigenous practices....

By Microdose

Finance

15 Aug 2023

Cybin Reports Q1 Financial Results and Business Highlights

Cybin reports first quarter financial results and business highlights, including updates on key trials....

By Microdose

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

You Might Also Like

11 Aug 2026

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High

Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the antidepressant benefits people associate with psychedelics without the trip? On...

By Madison Roberts

28 Jul 2026

FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.

For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies developing psilocybin, LSD, MDMA, and next-generation psychedelic-inspired compounds have often found themselves navigating a clinical landscape...

By Madison Roberts

13 Jul 2026

The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet

The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psychedelic medicine would quickly transform mental healthcare. Reality, however, proved more complicated....

By Madison Roberts

28 May 2026

Medical Psilocybin Act

New York lawmakers are officially considering the “Medical Psilocybin Act,” legislation that would create legal access to psilocybin therapy for conditions like PTSD, treatment-resistant depression, substance use disorders, end-of-life distress,...

By Madison Roberts

5 May 2026

PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field

By Madison Roberts

21 Apr 2026

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

President Donald Trump’s April 2026 executive order on accelerating treatments for serious mental illness does something the psychedelic industry has been waiting for, and quietly fearing. It removes ambiguity. For...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.